| pubmed-article:2301903 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2301903 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:2301903 | lifeskim:mentions | umls-concept:C0162473 | lld:lifeskim |
| pubmed-article:2301903 | lifeskim:mentions | umls-concept:C0701858 | lld:lifeskim |
| pubmed-article:2301903 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:2301903 | lifeskim:mentions | umls-concept:C0051512 | lld:lifeskim |
| pubmed-article:2301903 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2301903 | pubmed:dateCreated | 1990-3-2 | lld:pubmed |
| pubmed-article:2301903 | pubmed:abstractText | Nine patients suffering from gustatory sweating (Frey's syndrome) following parotidectomy have been treated by topical applications of aluminium chloride hexahydrate. Treatment has successfully controlled gustatory sweating using application intervals varying from 1 to 50 days. | lld:pubmed |
| pubmed-article:2301903 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2301903 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2301903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2301903 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2301903 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:2301903 | pubmed:issn | 0035-8843 | lld:pubmed |
| pubmed-article:2301903 | pubmed:author | pubmed-author:GunnAA | lld:pubmed |
| pubmed-article:2301903 | pubmed:author | pubmed-author:BlackM JMJ | lld:pubmed |
| pubmed-article:2301903 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2301903 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:2301903 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2301903 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2301903 | pubmed:pagination | 49-52 | lld:pubmed |
| pubmed-article:2301903 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:meshHeading | pubmed-meshheading:2301903-... | lld:pubmed |
| pubmed-article:2301903 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2301903 | pubmed:articleTitle | The management of Frey's syndrome with aluminium chloride hexahydrate antiperspirant. | lld:pubmed |
| pubmed-article:2301903 | pubmed:affiliation | Royal Victoria Infirmary, Newcastle upon Tyne. | lld:pubmed |
| pubmed-article:2301903 | pubmed:publicationType | Journal Article | lld:pubmed |
